Archive

Type 2 diabetes increased by almost 20% over a decade

Written by | 25 Aug 2024

Type 2 diabetes increased by almost 20% between 2012 and 2022, according to a new study from the University of Georgia. The researchers found an increase in diabetes among all […]

New UH study targets early signs of vision loss in diabetic patients

Written by | 21 Aug 2024

A $3.3 million study at the University of Houston College of Optometry will track the health of patients with prediabetes and diabetes to find out who might develop […]

The long-lasting impact of war on global diabetes prevalence

Written by | 14 Aug 2024

The ongoing war between Russia and Ukraine has led to severe humanitarian crises, including widespread food shortages. According to the United Nations World Food Programme, an estimated 11 […]

Exploding popularity of Ozempic and Wegovy among privately insured patients may worsen disparities

Written by | 5 Aug 2024

A new USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity are less likely to get them than those with […]

Pandemic exacerbated depression in older adults with diabetes

Written by | 3 Aug 2024

A recent study of more than 2,700 older Canadians reported older adults with diabetes faced a heightened risk of depression during the COVID-19 pandemic. In this cohort, almost 50% […]

Study examines prescribing patterns of drug associated with cognitive impairment

Written by | 2 Jun 2024

Many adults with diabetes and the associated complication of peripheral neuropathy, which can be painful as well as harmful, are often prescribed drugs at doses and for durations […]

Older adults with diabetes experienced functional decline during the COVID-19 pandemic

Written by | 22 Apr 2024

Researchers found that approximately 1 in 5 older Canadian adults with diabetes and no pre-pandemic functional limitations developed functional limitations for the first time during the COVID-19 pandemic. […]

This outdated diabetes drug still has something to offer

Written by | 17 Apr 2024

Thiazolidinediones (TZDs) are a class of drug that can be used to treat type 2 diabetes by reversing insulin resistance, one of the main hallmarks of the disease. […]

UH College of Pharmacy researcher examines trends in rising cost of medicine

Written by | 12 Apr 2024

Newly published research from the University of Houston College of Pharmacy reveals an alarming trend in diabetic medication expenditures. While pharmaceutical spending in the U.S. has long been […]

Reducing diabetes medication costs can help improve outcomes, especially for low-income patients

Written by | 17 Feb 2024

A new study led by researchers at the Harvard Pilgrim Health Care Institute has found that reducing out-of-pocket costs for patients with diabetes, especially those considered low income, […]

High weekly physical activity levels linked to lower kidney disease risk in diabetes + overweight/obesity

Written by | 9 Feb 2024

Clocking up high weekly levels of moderate to vigorous intensity physical activity is linked to a lower risk of developing chronic kidney disease in overweight/obese people with type […]

Diabetes drug appears to prevent substantial weight gain in female ex-smokers

Written by | 22 Dec 2023

Dulaglutide.  a Type 2 diabetes treatment, appears to significantly lower the risk of weight gain among women who have stopped smoking, researchers reported after a secondary analysis of […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.